Tunch Akmandor, Biomedical Scientist and Researcher in Histopathology and OncoPathology at University College London Hospitals NHS Foundation Trust, shared on LinkedIn:
“ESTRO meets Asia 2026 in Singapore
It was a pleasure to present our work, Early Clinical Outcomes of Alpha DaRT for Cutaneous Malignancies: Single-Institution Experience from the Clinical Trial (NCT04377360). Mark D’Andrea MD
This work explores the early clinical experience of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) in patients with cutaneous malignancies, including feasibility, tolerability, and early treatment outcomes. Alpha Tau Medical
Singapore
Poster P-168
I am also very grateful to be attending the congress alongside Ooi Po Lin and colleagues from the Clinical Oncology team at University Malaya Medical Centre (UMMC), where I am currently undertaking my clinical oncology internship. It has been a valuable opportunity to learn from the team both clinically and academically, and to experience the congress together here in Singapore.
A great first day of discussions on precision radiotherapy, radiation oncology, and multidisciplinary cancer care, while connecting with colleagues from across Asia and around the world.”
Other articles featuring Tunch Akmandor on OncoDaily.
